Today's Hours: 12:00pm - 8:00pm
Lane Medical Library

Search

Filter Applied Clear All

Filter Results

Did You Mean:

Search Results

  • Article
    Peter HH, Deutschmann EM, Schultheis W, Deicher H.
    Dev Biol Stand. 1977 Apr 13-15;38:537-40.
    23 "high risk" melanoma patients treated with BCG-AIT are compared with a non-randomized control group of 35 Stage II melanoma patients receiving other treatment. The results are discussed. It has been noted that patients with weak initial BCG reactions survived longer than patients with strongly positive first BCG reactions. This observation could be interesting for the choice of immunotherapy.
    Digital Access Access Options